SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-038985
Filing Date
2023-05-12
Accepted
2023-05-12 16:01:42
Documents
53
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_adialpharm.htm   iXBRL 10-Q 402313
2 CERTIFICATION f10q0323ex31-1_adialpharm.htm EX-31.1 11466
3 CERTIFICATION f10q0323ex31-2_adialpharm.htm EX-31.2 11572
4 CERTIFICATION f10q0323ex32-1_adialpharm.htm EX-32.1 4889
5 CERTIFICATION f10q0323ex32-2_adialpharm.htm EX-32.2 4807
  Complete submission text file 0001213900-23-038985.txt   3131239

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adil-20230331.xsd EX-101.SCH 51187
7 XBRL CALCULATION FILE adil-20230331_cal.xml EX-101.CAL 24063
8 XBRL DEFINITION FILE adil-20230331_def.xml EX-101.DEF 174791
9 XBRL LABEL FILE adil-20230331_lab.xml EX-101.LAB 374628
10 XBRL PRESENTATION FILE adil-20230331_pre.xml EX-101.PRE 191975
47 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_adialpharm_htm.xml XML 253458
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 23915443
SIC: 2834 Pharmaceutical Preparations